glycerylphosphorylcholine has been researched along with Cerebral Small Vessel Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiti, G; Donnini, I; Fierini, F; Melone, A; Pantoni, L; Pescini, F; Poggesi, A; Rinnoci, V; Salvadori, E; Squitieri, M; Tudisco, L | 2 |
2 trial(s) available for glycerylphosphorylcholine and Cerebral Small Vessel Diseases
| Article | Year |
|---|---|
Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial.
Topics: Aged; Aged, 80 and over; Cerebral Small Vessel Diseases; Cognitive Dysfunction; Glycerylphosphorylcholine; Humans; Nimodipine; Quality of Life | 2021 |
Association of nimodipine and choline alphoscerate in the treatment of cognitive impairment in patients with cerebral small vessel disease: study protocol for a randomized placebo-controlled trial-the CONIVaD trial.
Topics: Aged; Calcium Channel Blockers; Cerebral Small Vessel Diseases; Cognitive Dysfunction; Dementia, Vascular; Drug Therapy, Combination; Female; Glycerylphosphorylcholine; Humans; Male; Middle Aged; Nimodipine; Randomized Controlled Trials as Topic | 2020 |